false 0001715819 0001715819 2024-05-17 2024-05-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 17, 2024

 

 

 

ELECTROMEDICAL TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware Commission File Number 82-2619815
(State or other jurisdiction of
incorporation or organization)		 000-56192 (I.R.S. Employer
Identification Number)

 

16561 N. 92nd Street, Ste. 101

Scottsdale, AZ 85260

 (Address of Principal Executive Offices and Zip Code) 

 

888-880-7888

(Issuer's telephone number)

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class Trading Symbols Name of Exchange on Which Registered
COMMON EMED NONE

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 4.01 Changes in Registrant’s Certifying Accountant.

 

On May 17, 2024, dbbmckennon declined to stand for reelection as the Registrant’s independent registered public accounting firm to audit the Registrant’s financial statements.  dbbmckennon's reports on the Registrant’s financial statements for the past two years, which contained an explanatory paragraph regarding the Company’s ability to continue as a going concern as a result of recurring losses and working capital deficit, did not contain an adverse opinion or a disclaimer of opinion, or was qualified or modified as to uncertainty, audit scope, or matter of accounting principles or practices, financial statement disclosure or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of dbbmckennon, would have caused dbbmckennon to make reference to such disagreement in its report. The dismissal of dbbmckennon was approved by the Registrant’s board of directors. During the two most recent fiscal years, and any subsequent interim period through the date of dismissal, there have been no disagreements with dbbmckennon or certain other reportable events. Pursuant to Item 304(a)(3) of Reg. SK, prior to this filing the Registrant provided dbbmckennon with a copy of its disclosures and requested dbbmckennon to provide the Registrant with a letter addressed to the Commission indicating whether it agrees with the Registrant’s disclosures. The Registrant will file an amendment to this Form 8-K upon receipt of the letter from dbbmckennon.

 

(b) On May 17, 2024, the Registrant engaged Hudgens, CPA, PLLC ("Hudgens") as its principal accountant to audit the Registrant’s financial statements. During the Registrant’s two most recent fiscal years, and any subsequent interim period prior to engaging Hudgens, neither the Registrant nor anyone acting on its behalf consulted with Hudgens regarding (i) either the application of any accounting principles to a specific completed or contemplated transaction of the Registrant, or the type of audit opinion that might be rendered by Hudgens on the Registrant’s financial statements; or (ii) any matter that was either the subject of any disagreement with the Registrant’s former independent auditor, dbbmckennon, or any reportable event with respect to dbbmckennon.

 

SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

Exhibit No. Document Location
16.1 Letter from dbbmckennon dated May 21, 2024, to the Securities and Exchange Commission. Filed herewith
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)  

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated May 21, 2024

 

ELECTROMEDICAL TECHNOLOGIES, INC.  
(Registrant)  
   
By: /s/ Matthew Wolfson  
Matthew Wolfson  
Principal Executive Officer  

 

 

 

Exhibit 16.1

 

May 21, 2024

 

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

 

Dear Commissioners:

 

We have read the statements made by Electromedical Technologies, Inc. (the “Company”), which we understand will be filed with the Securities and Exchange Commission. Pursuant to Item 4.01 of Form 8-K filed by the Company and dated May 21, 2024, we are in agreement with the statements contained in Item 4.01 insofar as they relate to dbbmckennon.

 

Very truly yours,  
   
/s/ dbbmckennon  
dbbmckennon  

 

 

 

v3.24.1.1.u2
Cover
May 17, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 17, 2024
Entity File Number 000-56192
Entity Registrant Name ELECTROMEDICAL TECHNOLOGIES, INC.
Entity Central Index Key 0001715819
Entity Tax Identification Number 82-2619815
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 16561 N. 92nd Street
Entity Address, Address Line Two Ste. 101
Entity Address, City or Town Scottsdale
Entity Address, State or Province AZ
Entity Address, Postal Zip Code 85260
City Area Code 888
Local Phone Number 880-7888
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security COMMON
Trading Symbol EMED
Security Exchange Name NONE
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
ElectroMedical Technolog... (PK) (USOTC:EMED)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos ElectroMedical Technolog... (PK).
ElectroMedical Technolog... (PK) (USOTC:EMED)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos ElectroMedical Technolog... (PK).